X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2556) 2556
Publication (512) 512
Book Review (181) 181
Book Chapter (7) 7
Conference Proceeding (5) 5
Dissertation (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2345) 2345
forkhead box protein o1 (1719) 1719
humans (1534) 1534
animals (1531) 1531
mice (1152) 1152
forkhead transcription factors - metabolism (1096) 1096
forkhead transcription factors - genetics (762) 762
male (669) 669
phosphorylation (636) 636
signal transduction (568) 568
biochemistry & molecular biology (556) 556
cell biology (541) 541
expression (502) 502
apoptosis (501) 501
female (501) 501
foxo1 (462) 462
gene expression (437) 437
transcription factors (427) 427
proteins (421) 421
proto-oncogene proteins c-akt - metabolism (421) 421
forkhead transcription factors (377) 377
oncology (371) 371
gene-expression (353) 353
cells, cultured (350) 350
cell line, tumor (346) 346
mice, inbred c57bl (346) 346
forkhead box protein o1 - metabolism (341) 341
oxidative stress (336) 336
insulin (335) 335
activation (322) 322
foxo1 protein (317) 317
endocrinology & metabolism (313) 313
article (290) 290
cancer (288) 288
cell line (287) 287
forkhead transcription factor (282) 282
transcription factors - metabolism (279) 279
metabolism (278) 278
gene expression regulation (274) 274
research (263) 263
mice, knockout (261) 261
forkhead protein (256) 256
transcription factors - genetics (255) 255
kinases (254) 254
cell proliferation (253) 253
physiological aspects (243) 243
endocrine system (233) 233
rodents (231) 231
abridged index medicus (230) 230
hormones, hormone substitutes, and hormone antagonists (228) 228
akt (220) 220
forkhead box protein o1 - genetics (220) 220
forkhead box protein o3 (219) 219
differentiation (218) 218
genetic aspects (218) 218
glucose (216) 216
analysis (215) 215
rats (215) 215
insulin resistance (214) 214
signal transduction - drug effects (214) 214
phosphatidylinositol 3-kinases - metabolism (211) 211
liver - metabolism (207) 207
research article (204) 204
cells (201) 201
liver (199) 199
forkhead transcription factors - physiology (198) 198
multidisciplinary sciences (194) 194
insulin - metabolism (192) 192
diabetes (183) 183
homeostasis (182) 182
dna-binding proteins - metabolism (180) 180
medicine, research & experimental (179) 179
genes (173) 173
gene expression regulation, neoplastic (172) 172
cell cycle (170) 170
proliferation (167) 167
glucose - metabolism (164) 164
blotting, western (163) 163
reverse transcriptase polymerase chain reaction (163) 163
dna-binding proteins - genetics (162) 162
health aspects (159) 159
rna, messenger - metabolism (157) 157
apoptosis - drug effects (155) 155
middle aged (155) 155
medicine (150) 150
physiology (150) 150
down-regulation (149) 149
inhibition (148) 148
up-regulation (148) 148
adult (147) 147
pathway (145) 145
transcription, genetic (145) 145
transfection (145) 145
insulin-resistance (143) 143
mice, transgenic (143) 143
immunology (142) 142
transcription (141) 141
transcription factor foxo1 (137) 137
gene (135) 135
signal transduction - physiology (135) 135
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2505) 2505
Chinese (23) 23
Japanese (16) 16
French (5) 5
Spanish (4) 4
Russian (3) 3
Polish (2) 2
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 06/2019, Volume 852, pp. 142 - 150
Diabetic nephropathy (DN) is the most common complication of diabetes mellitus. Atrasentan (Atr) has potential therapeutic values for DN. MicroRNAs (miRNAs)... 
Forkhead box O1 | Diabetic nephropathy | MicroRNA-21 | Atrasentan | APOPTOSIS | DOWN-REGULATION | DIABETIC-NEPHROPATHY | CELL-PROLIFERATION | AUTOPHAGY | FOXO1 | PROTECTS | OVEREXPRESSION | MIR-21 | PHARMACOLOGY & PHARMACY | DYSFUNCTION | Antimitotic agents | MicroRNA | Blood sugar | Analysis | Diabetes | Kidney diseases | Antineoplastic agents | Health aspects | Index Medicus
Journal Article
Gene, ISSN 0378-1119, 08/2019, Volume 708, pp. 49 - 56
Forkhead box O1 ( ) is a transcription factor and plays important roles in glucose metabolism. In the present study, in turbot was cloned and characterized.... 
Forkhead box O1 | siRNA | Turbot | Glucose | Metabolism | CARBOHYDRATE | FOXO1 | GLUCONEOGENESIS | STARCH | GROWTH | LIVER | GENETICS & HEREDITY | FISH | INSULIN-BINDING | EXPRESSION | DIETS | Isoenzymes | Blood sugar | Glycogen | Analysis | Fishes | Physiological aspects | Genetic research | Genetic aspects | Index Medicus
Journal Article
Journal Article
Journal Article
JOURNAL OF BIOLOGICAL CHEMISTRY, ISSN 0021-9258, 05/2019, Volume 294, Issue 21, pp. 8424 - 8437
Journal Article
Stem Cells and Development, ISSN 1547-3287, 03/2013, Volume 22, Issue 6, pp. 878 - 888
Journal Article
Journal Article
British Journal of Nutrition, ISSN 0007-1145, 04/2018, Volume 119, Issue 7, pp. 727 - 733
Journal Article
Molecular Endocrinology, ISSN 0888-8809, 02/2010, Volume 24, Issue 2, pp. 370 - 380
Journal Article
Oncology Reports, ISSN 1021-335X, 03/2018, Volume 39, Issue 3, pp. 1034 - 1042
Gonadotropins, including luteinizing hormone (LH) and follicle stimulating hormone (FSH), are conducive to the growth of ovarian cancer based on the... 
Forkhead box O1 | Epithelial ovarian cancer | PI3K/AKT signaling pathway | Goserelin | Gonadotropin-releasing hormone agonist | Apoptosis | TRANSCRIPTION FACTORS | SURVIVAL | ACTIVATION | goserelin | GONADOTROPIN-RELEASING-HORMONE | apoptosis | PROLIFERATION | FOXO1 | BREAST-CANCER | OVEREXPRESSION | ARREST | ONCOLOGY | PROSTATE-CANCER | gonadotropin-releasing hormone agonist | epithelial ovarian cancer | forkhead box O1 | Up-Regulation | Phosphorylation | Apoptosis - drug effects | Humans | Ovarian Neoplasms - pathology | Neoplasms, Glandular and Epithelial - metabolism | Proto-Oncogene Proteins c-akt - genetics | Biomarkers, Tumor - metabolism | Female | Ovarian Neoplasms - metabolism | Tumor Cells, Cultured | Proto-Oncogene Proteins c-akt - metabolism | Ovarian Neoplasms - drug therapy | Phosphatidylinositol 3-Kinase - metabolism | Forkhead Box Protein O1 - metabolism | Neoplasms, Glandular and Epithelial - pathology | Antineoplastic Agents, Hormonal - pharmacology | Xenograft Model Antitumor Assays | Animals | Goserelin - pharmacology | Phosphatidylinositol 3-Kinase - genetics | Signal Transduction - drug effects | Mice, Nude | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | Mice | Forkhead Box Protein O1 - genetics | Care and treatment | Oncology, Experimental | Development and progression | Gonadotropin | Research | Carcinogenesis | Ovarian cancer | Physiological aspects | Dosage and administration | Pharmacokinetics | Health aspects | Cancer | Proteins | Flow cytometry | Hypotheses | Medical prognosis | Genes | Cell cycle | Ligands | Tumor necrosis factor-TNF | Breast cancer | Polyclonal antibodies | Index Medicus | PI3K | AKT signaling pathway
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, pp. e0145130 - e0145130
Hypertension is an independent risk factor for the progression of chronic renal failure, and oxidative stress plays a critical role in hypertensive renal... 
P38 | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | RENAL STRUCTURE | TRANSCRIPTION | DISEASE | GINSENOSIDE RG1 | MESENCHYMAL TRANSITION | PODOCYTES | BLOOD-PRESSURE | DAMAGE | Rats, Inbred SHR | Cytokines - metabolism | Oxidative Stress | Rats, Wistar | Drugs, Chinese Herbal - pharmacology | Rats | Male | Antioxidants - pharmacology | Catalase - metabolism | Hypertension, Renal - drug therapy | Nerve Tissue Proteins - metabolism | Antioxidants - therapeutic use | Animals | Proteinuria - drug therapy | Mitogen-Activated Protein Kinase 3 - metabolism | Forkhead Transcription Factors - metabolism | p38 Mitogen-Activated Protein Kinases - metabolism | Drugs, Chinese Herbal - therapeutic use | Superoxide Dismutase - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism | Hypertension | Oxidative stress | Complications and side effects | Care and treatment | Physiological aspects | Genetic aspects | Cellular signal transduction | Research | Kidney diseases | Risk factors | Transcription factors | Syngeneic grafts | Pathogenesis | Smooth muscle | NAD(P)H oxidase | Metastases | Antioxidants | Signal transduction | Chinese medicine | Forkhead protein | Blood pressure | Inhibition | Stresses | Enzymes | NADPH-diaphorase | Malondialdehyde | Hospitals | Molecular modelling | Fibrosis | Renal failure | Nicotinamide adenine dinucleotide | Nicotinamide | Infiltration | Phosphates | Carbonyl compounds | Phosphorylation | Laboratories | Interleukin | Homology | Superoxide dismutase | Kinases | Interleukin 6 | FOXO1 protein | Catalase | Actin | Rodents | Extracellular matrix | Cardiology | Injuries | Carbonyls | Creatinine | Urine | Excretion | Kidneys | Muscles | Adenine | Traditional Chinese medicine | Histology | Inflammation | Angina pectoris | Stress | Signaling | Diabetes | Manganese | Index Medicus
Journal Article
International Journal of Clinical and Experimental Pathology, ISSN 1936-2625, 2016, Volume 9, Issue 12, pp. 12502 - 12510
The gluconeogenesis pathway was considered as a potential therapeutic target for preventing type 2 diabetes (T2D). Recently, the emergence of (miRNAs, miRs) as... 
Type 2 diabetes | Forkhead Box O1 | Hepatic gluconeogenesis | MicroRNA-223 | INSULIN | GLUCOSE-6-PHOSPHATASE | microRNA-223 | type 2 diabetes | METABOLISM | ONCOLOGY | GENE-EXPRESSION | PATHOLOGY | GLUCOSE-PRODUCTION
Journal Article